The karas study renews concerns about cancer , as well 格拉瑞博士的研究使人重新关注癌症
2.
Karas and colleagues examined the records of patients treated with popular statins , including pfizer inc . ' s lipitor and merck & co . inc . ' s zocor , now off patent 格拉瑞博士和同事检查服用流行性他汀类药物患者的记录,包括现在还没有药品专利的辉瑞公司的阿托和马瑞克有限公司的舒降之
3.
" the demonstrated benefits of statins in lowering the risk of heart disease remain clear ; however , certain aspects of lowering ldl with statins remain controversial and merit further research , " karas said in a statement 他们这项研究也被称为梅塔分析,他们分析了41 , 173例病人的病例,发现有23例不同症状与他汀类药物有关
